Part of Cancer staging guidance sheets
Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
Current Chapter
Current chapter – Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
Page contents
Stage groupings
|
FIGO Stage |
Description |
|---|---|
|
I |
Tumour confined to ovaries or fallopian tube(s) IA - Tumour limited to 1 ovary (capsule intact) or fallopian tube; no tumour on ovarian or fallopian tube surface; no malignant cells in the ascites or peritoneal washings IB - Tumour limited to both ovaries (capsules intact) or fallopian tubes; no tumour on ovarian or fallopian tube surface; no malignant cells in the ascites or peritoneal washings IC1 - Surgical spill IC2 - Capsule ruptured before surgery or tumour on ovarian or fallopian tube surface IC3 - Malignant cells in the ascites or peritoneal washings |
|
II |
Tumour involves 1 or both ovaries or fallopian tubes with pelvic extension (below pelvic brim) or peritoneal cancer IIA - Extension and/or implants on uterus and/or fallopian tubes and/or ovaries IIB - Extension to other pelvic intraperitoneal tissues |
|
III |
Tumour involves 1 or both ovaries or fallopian tubes, or peritoneal cancer, with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes IIIA1 - Positive retroperitoneal lymph nodes only (cytologically or histologically proven): IIIA1(i) - Metastasis up to 10 mm in greatest dimension IIIA1(ii) - Metastasis more than 10 mm in greatest dimension IIIA2 - Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes IIIB - Macroscopic peritoneal metastasis beyond the pelvis up to 2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes IIIC - Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumour to capsule of liver and spleen without parenchymal involvement of either organ) |
|
IV |
Distant metastasis excluding peritoneal metastases IVA - Pleural effusion with positive cytology IVB - Parenchymal metastases and metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity) |
Download
Click on the box below to download a PDF version of this data sheet:
Last edited: 21 December 2022 5:49 pm
- Cancer staging guidance sheets
- Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
- Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
- Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
- Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
- Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
- Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
- Stomach (ICD10 C16 - excluding C16.0)
- Small intestine (ICD10 C17)
- Appendix (ICD10 C18.1)
- Colon and rectum (ICD10 C18-C20)
- Anal and perianal skin (ICD10 C21)
- Liver (ICD10 C22.0)
- Intrahepatic bile ducts (ICD10 C22.1)
- Gallbladder (ICD10 C23)
- Distal extrahepatic bile duct (ICD10 C24.0)
- Perihilar bile ducts (ICD10 C24.0)
- Ampulla of vater (ICD10 C24.1)
- Pancreas (ICD10 C25)
- Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
- Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
- Lung (ICD10 C34)
- Thymus tumours (ICD10 C37.9)
- Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
- Bone (ICD10 C40, C41)
- Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
- Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
- Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
- Carcinoma of skin of the eyelid (ICD10 C44.1)
- Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
- Pleural mesothelioma (ICD10 C38.4)
- Breast tumours (ICD10 C50)
- Vulva (ICD10 C51)
- Cervix uteri (ICD10 C53)
- Uterine sarcomas
- Uterus - endometrium (ICD10 C54.1, C55)
- Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
- Gestational trophoblastic neoplasms (ICD10 C58)
- Penis tumours (ICD10 C60)
- Prostate tumours (ICD10 C61.9)
- Testis tumours (ICD10 C62)
- Kidney tumours (ICD10 C64)
- Renal pelvis and ureter tumours (ICD10 C65 & C66)
- Urinary bladder tumours (ICD10 C67)
- Urethra tumours (ICD10 C68.0, C61.9)
- Carcinoma of conjuctiva (ICD10 C69.0)
- Melanoma of conjuctiva (ICD10 C69.0)
- Retinoblastoma (ICD10 C69.2)
- Melanoma of uvea (ICD10 C69.3-4)
- Carcinoma of lacrimal gland (ICD10 C69.5)
- Sarcoma of orbit (ICD10 C69.6)
- Thyroid gland (ICD10 C73.9)
- Adrenal cortex (ICD10 C74.0)
- Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
- Parathyroid gland (ICD10 C75.0)
- Unknown primary - cervical nodes (ICD10 C77.0)
- Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
- T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
- Rhabdomyosarcoma (CTYA)
- Chronic lymphocytic leukaemia
- Hepatoblastoma (CTYA)
- Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
- Medulloblastoma
- Multiple myeloma
- Neuroblastoma
- Neuroendocrine tumours of the foregut
- Neuroendocrine tumours of the midgut and hindgut
- Non-hodgkin lymphoma (children)
- Wilms tumour of the kidney